PROVIDER PROFILE · NPI 1487114401
Emma Fitzgibbon
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
434
Beneficiaries
—
Total drug cost
$886K
Distinct drugs
7
Brand share
97.5%
Top prescribed drugs
Emtricitabine/Tenofov Alafenam303 claims
Dolutegravir Sodium34 claims
Bictegrav/Emtricit/Tenofov Ala33 claims
Emtricitabine/Tenofovir (Tdf)14 claims
Emtricitabine/Tenofovir (Tdf)13 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
CROSS-REFERENCE